We’ve discussed the prospects for and likelihood of Yen weakness going back to summer 2012 and our general belief here has been a simple one: so long as reflation is and remains the core pillar of Abenomics, so too must the…...
I wanted to build off the simple short-termist statistical analysis on the Nikkei posted earlier today with a similar analog/technical round-up on the index as well. What we’re trying to do today is tie our short-term views on the index…...
As of Wednesday 5/6 the USD-denominated, CME-listed Nikkei futures contract (NKc1) had been down 8 of 10 days. We can’t run the same analysis on the actual Nikkei index itself because Japanese markets were closed on 4/29 and 5/4-5/6, or four…...
Below is a quick update to our recent pivot point analog post on the Nikkei a few weeks ago in which we outlined our belief that the BoJ was unlikely to expand the scope of its QE program at its next…...
Beginning with this piece from July 2013 in which we juxtaposed our bullish view on the prospects for Chinese equities with Barron’s call for an imminent credit crisis there, I’d like to believe my work on the region in recent times has…...
The BoJ has upcoming monetary policy meetings/announcements as follows. I consider the latter schedule very important v-a-v our ongoing assessment of the Nikkei’s progress relative to our 6 mo RoC framework. Specifically, I find the 4/30 and 5/21 policy dates…...
If anybody watched the 2012 presidential debates they’ll remember the laps Romney ran around Obama as well as his prescience on many geopolitical items that have since come to fruition (the likelihood of Russian aggression , for instance, an idea Obama condescendingly mocked…
In the chart below VIX futures are breaking down from a ~one-year flag pattern formed b/t lines (1) and (2) on a daily basis. Presumably, this implies U.S.-based equity VOL is set to fall over the near to intermediate-term. At…...
We originally added our Nikkei pivot point logic to our overall framework of analyzing the index in early December of last year in this post. Thus far, the path the Nikkei has traveled following its 10/17/14 pivot point low print of…...
We’ve been bullish on biotech for a long, long time dating back to summer 2012 in posts outlined here and here. Despite many calling for tops in the space for quite some time, I’ve been reticent to do so, outlining…...